ICICI Securities Ltd | Retail Equity Research Revenues grew 36.2% YoY to | 1872 crore (I-direct estimate: | 1895.5 crore) mainly due to 78.9% YoY growth in Indian formulations to | 830 crore (I-direct estimate: | 824.9 crore) led by lower base, consolidation of Unichem India & Nepal businesses. US business grew 22.8% YoY to | 334 crore (I-direct estimate: | 343.8 crore) EBITDA margins improved 387 bps YoY to 25.5% YoY (I-direct estimate: 24.5%) mainly due to lower other expenditure. EBITDA...